Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingyan Zhu

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Pesticide Science|December 8, 2022
Discovery of novel pyridine carboxamides with antifungal activity as potential succinate dehydrogenase inhibitorsZhongzhong Yan, Zihui Yang, Longjian Qiu, et al.
Research (Washington, D.C.)|July 9, 2026
Photo-Induced Synthesis of Bioplastics from XylanSiyu Jia, Zixing Feng, Xueqing Yan, et al.
Journal of Materials Chemistry. B|March 9, 2023
Armoring a liposome-integrated tissue factor with sacrificial CaCO<sub>3</sub> to form potent self-propelled hemostatsChengkun Liu, Zhuang Shi, Jingyan Zhu, et al.
Science Signaling|July 11, 2013
JNK3 couples the neuronal stress response to inhibition of secretory traffickingGuang Yang, Xun Zhou, Jingyan Zhu, et al.
International Immunopharmacology|December 3, 2022
Tacrolimus ameliorates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via JAK2/STAT3 signalingBowen Liu, Qiuyan Jiang, Ruxuan Chen, et al.
Pharmacological Research|April 7, 2024
IL20Rb aggravates pulmonary fibrosis through enhancing bone marrow derived profibrotic macrophage activationJingyan Zhu, Qiuyan Jiang, Shaoyan Gao, et al.
Menopause (New York, N.Y.)|July 22, 2025
Therapeutic efficacy of Yangyin Shugan capsules against premature ovarian insufficiency: results from a multicenter, placebo-controlled trialXiaojing Cao, Lei Song, Jiarui Hou, et al.
Cellular Signalling|June 11, 2025
The novel diarylurea derivative HPT-15 for potential treatment of triple-negative breast cancer via dual inhibition of the mTOR and MAPK pathwaysYujie Wang, Huanhuan Wu, Jiale Luo, et al.
International Immunopharmacology|March 15, 2024
Favipiravir ameliorates bleomycin-induced pulmonary fibrosis by reprogramming M1/M2 macrophage polarizationRuiqin Zhang, Qiuyan Jiang, Shaoyan Gao, et al.
International Immunopharmacology|April 6, 2024
Tacrolimus alleviates pulmonary fibrosis progression through inhibiting the activation and interaction of ILC2 and monocytesBowen Liu, Qiuyan Jiang, Ruxuan Chen, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Pesticide Science|December 8, 2022
Discovery of novel pyridine carboxamides with antifungal activity as potential succinate dehydrogenase inhibitorsZhongzhong Yan, Zihui Yang, Longjian Qiu, et al.
Research (Washington, D.C.)|July 9, 2026
Photo-Induced Synthesis of Bioplastics from XylanSiyu Jia, Zixing Feng, Xueqing Yan, et al.
Journal of Materials Chemistry. B|March 9, 2023
Armoring a liposome-integrated tissue factor with sacrificial CaCO<sub>3</sub> to form potent self-propelled hemostatsChengkun Liu, Zhuang Shi, Jingyan Zhu, et al.
Science Signaling|July 11, 2013
JNK3 couples the neuronal stress response to inhibition of secretory traffickingGuang Yang, Xun Zhou, Jingyan Zhu, et al.
International Immunopharmacology|December 3, 2022
Tacrolimus ameliorates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via JAK2/STAT3 signalingBowen Liu, Qiuyan Jiang, Ruxuan Chen, et al.
Pharmacological Research|April 7, 2024
IL20Rb aggravates pulmonary fibrosis through enhancing bone marrow derived profibrotic macrophage activationJingyan Zhu, Qiuyan Jiang, Shaoyan Gao, et al.
Menopause (New York, N.Y.)|July 22, 2025
Therapeutic efficacy of Yangyin Shugan capsules against premature ovarian insufficiency: results from a multicenter, placebo-controlled trialXiaojing Cao, Lei Song, Jiarui Hou, et al.
Cellular Signalling|June 11, 2025
The novel diarylurea derivative HPT-15 for potential treatment of triple-negative breast cancer via dual inhibition of the mTOR and MAPK pathwaysYujie Wang, Huanhuan Wu, Jiale Luo, et al.
International Immunopharmacology|March 15, 2024
Favipiravir ameliorates bleomycin-induced pulmonary fibrosis by reprogramming M1/M2 macrophage polarizationRuiqin Zhang, Qiuyan Jiang, Shaoyan Gao, et al.
International Immunopharmacology|April 6, 2024
Tacrolimus alleviates pulmonary fibrosis progression through inhibiting the activation and interaction of ILC2 and monocytesBowen Liu, Qiuyan Jiang, Ruxuan Chen, et al.
Pageof 4